MicroRNA silencing and the development of novel therapies for liver disease

Journal of Hepatology

Volumn 57, Issue 2, 2012, Pages 462-466

  Szabo, Gyongyi ^a   Sarnow, Peter ^b   Bala, Shashi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty liver; Liver fibrosis; LNA; MicroRNA; Nanoparticle; RNA interference; Viral hepatitis

Indexed keywords

ANTAGOMIR; ANTISENSE OLIGONUCLEOTIDE; COLLAGENASE 3; LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 101; MICRORNA 122; MICRORNA 1224; MICRORNA 124; MICRORNA 146A; MICRORNA 15; MICRORNA 150; MICRORNA 155; MICRORNA 181A; MICRORNA 194; MICRORNA 198; MICRORNA 199B; MICRORNA 221; MICRORNA 222; MICRORNA 296; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; MICRORNA 351; MICRORNA 721; PROCOLLAGEN; SMALL INTERFERING RNA; SOLID LIPID NANOPARTICLE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; GENE SILENCING; GENE THERAPY; HEPATITIS B; HEPATITIS C; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS HEPATITIS;

EID: 84863983719     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.01.030     Document Type: Note

References (32)

1. R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 5 1993 843 854
2. S. Bala, M. Marcos, and G. Szabo Emerging role of microRNAs in liver diseases World J Gastroenterol 45 2009 5633 5640
3. T.A. Kerr, K.M. Korenblat, and N.O. Davidson MicroRNAs and liver disease Transl Res 4 2011 241 252
4. B.N. Davis, and A. Hata Regulation of microRNA biogenesis: a miRiad of mechanisms Cell Commun Signal 7 2009 18
5. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 2 2009 215 233
6. R. Garzon, S. Liu, M. Fabbri, Z. Liu, C.E. Heaphy, and E. Callegari MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 Blood 25 2009 6411 6418
7. A.M. Lakner, H.L. Bonkovsky, and L.W. Schrum microRNAs: fad or future of liver disease World J Gastroenterol 20 2011 2536 2542
8. D. Gatfield, G. Le Martelot, C.E. Vejnar, D. Gerlach, O. Schaad, and F. Fleury-Olela Integration of microRNA miR-122 in hepatic circadian gene expression Genes Dev 11 2009 1313 1326
9. A.P. Roberts, A.P. Lewis, and C.L. Jopling miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components Nucleic Acids Res 39 2011 7716 7729
10. C.L. Jopling, M. Yi, A.M. Lancaster, S.M. Lemon, and P. Sarnow Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA Science 5740 2005 1577 1581
11. R.E. Lanford, E.S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, and M.E. Munk Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 5962 2010 198 201
12. L. Qiu, H. Fan, W. Jin, B. Zhao, Y. Wang, and Y. Ju MiR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV Biochem Biophys Res Commun 4 2010 771 777
13. O. Cheung, and A.J. Sanyal Role of microRNAs in non-alcoholic steatohepatitis Curr Pharm Des 17 2010 1952 1957
14. O. Cheung, P. Puri, C. Eicken, M.J. Contos, F. Mirshahi, and J.W. Maher Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression Hepatology 6 2008 1810 1820
15. M.P. Czech, M. Aouadi, and G.J. Tesz RNAi-based therapeutic strategies for metabolic disease Nat Rev Endocrinol 8 2011 473 484
16. S. Bala, M. Marcos, K. Kodys, T. Csak, D. Catalano, and P. Mandrekar Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor alpha (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease J Biol Chem 2 2011 1436 1444
17. S.K. Venugopal, J. Jiang, T.H. Kim, Y. Li, S.S. Wang, and N.J. Torok Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation Am J Physiol Gastrointest Liver Physiol 1 2010 G101 G106
18. C. Roderburg, G.W. Urban, K. Bettermann, M. Vucur, H. Zimmermann, and S. Schmidt Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis Hepatology 1 2011 209 218
19. Y. Murakami, H. Toyoda, M. Tanaka, M. Kuroda, Y. Harada, and F. Matsuda The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families PLoS One 1 2011 e16081
20. S. Singh, A.S. Narang, and R.I. Mahato Subcellular fate and off-target effects of siRNA, shRNA, and miRNA Pharm Res 12 2011 2996 3015
21. J. Kota, R.R. Chivukula, K.A. O'Donnell, E.A. Wentzel, C.L. Montgomery, and H.W. Hwang Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model Cell 6 2009 1005 1017
22. T.C. Chang, D. Yu, Y.S. Lee, E.A. Wentzel, D.E. Arking, and K.M. West Widespread microRNA repression by Myc contributes to tumorigenesis Nat Genet 1 2008 43 50
23. C. Huynh, M.F. Segura, A. Gaziel-Sovran, S. Menendez, F. Darvishian, and L. Chiriboga Efficient in vivo microRNA targeting of liver metastasis Oncogene 12 2011 1481 1488
24. C. Qiao, Z. Yuan, J. Li, B. He, H. Zheng, and C. Mayer Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver Gene Ther 4 2011 403 410
25. F. Mingozzi, M.V. Maus, D.J. Hui, D.E. Sabatino, S.L. Murphy, and J.E. Rasko CD8(+) T-cell responses to adeno-associated virus capsid in humans Nat Med 4 2007 419 422
26. C. Esau, S. Davis, S.F. Murray, X.X. Yu, S.K. Pandey, and M. Pear MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metab 2 2006 87 98
27. J. Elmen, M. Lindow, A. Silahtaroglu, M. Bak, M. Christensen, and A. Lind-Thomsen Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver Nucleic Acids Res 4 2008 1153 1162
28. Y. Wu, M. Crawford, B. Yu, Y. Mao, S.P. Nana-Sinkam, and L.J. Lee MicroRNA delivery by cationic lipoplexes for lung cancer therapy Mol Pharm 4 2011 1381 1389
29. A. Akinc, M. Goldberg, J. Qin, J.R. Dorkin, C. Gamba-Vitalo, and M. Maier Development of lipidoid-siRNA formulations for systemic delivery to the liver Mol Ther 5 2009 872 879
30. S. Anand, B.K. Majeti, L.M. Acevedo, E.A. Murphy, R. Mukthavaram, and L. Scheppke MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis Nat Med 8 2010 909 914
31. J. Su, H. Baigude, J. McCarroll, and T.M. Rana Silencing microRNA by interfering nanoparticles in mice Nucleic Acids Res 6 2011 e38
32. X.Q. Liu, W.J. Song, T.M. Sun, P.Z. Zhang, and J. Wang Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles Mol Pharm 1 2011 250 259